Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease

 
• By Lucie Ellis-Taitt

Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity. 

In Vivo Podcast
• Source: Shutterstock

More from Innovation

More from In Vivo